Evidence map›Paper›PMID 36852114›Full record

ArticleClinical case reports2023

Guillain-Barre syndrome associated with COVID-19 infection: A case series.

Ayman Ahmed, Rahba El-Amin, Ahmed Mudawi Musa, Muaz A Elsayed, Lamis Ahmed Fahal, Eiman Siddig Ahmed, Yousif Ali, Ipyn Eric Nebie, Nouh Saad Mohamed, Jakob Zinsstag and 2 more

Abstract readCase Reports
In one paragraph

Article in Clinical case reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. The firstClinical case reports · 2023
    Article
  3. Delayed cerebellar ataxia induced byClinical case reports · 2023
    Article
  4. Article
  5. Article
  6. Article
  7. The First Case ofJournal of fungi (Basel, Switzerland) · 2023
    Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Ayman AhmedInstitute of Endemic Disease University of Khartoum Khartoum Sudan.ORCID https://orcid.org/0000-0002-9516-9508
Rahba El-AminFaculty of Medicine University of Khartoum Khartoum Sudan.
Ahmed Mudawi MusaInstitute of Endemic Disease University of Khartoum Khartoum Sudan.
Muaz A ElsayedFaculty of Medicine Omdurman Islamic University Khartoum Sudan.
Lamis Ahmed FahalMycetoma Research Centre University of Khartoum Khartoum Sudan.
Eiman Siddig AhmedMycetoma Research Centre University of Khartoum Khartoum Sudan.
Yousif AliHealth Emergencies and Epidemics Control General Directorate Sudan Federal Ministry of Health Khartoum Sudan.
Ipyn Eric NebieSwiss Tropical and Public Health Institute (Swiss TPH) Allschwil Switzerland.
Nouh Saad MohamedMolecular Biology Unit Sirius Training and Research Centre Khartoum Sudan.
Jakob ZinsstagSwiss Tropical and Public Health Institute (Swiss TPH) Allschwil Switzerland.
Emmanuel Edwar SiddigMycetoma Research Centre University of Khartoum Khartoum Sudan.ORCID https://orcid.org/0000-0001-6314-7374
Sarah Misbah El-SadigFaculty of Medicine University of Khartoum Khartoum Sudan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this communication, we reported a series of six patients presented with Guillain-Barré syndrome that associated with COVID-19 infection, which was confirmed with RT-PCR. Here we discuss the laboratory investigation and case management, as well as clinical presentation and outcome of each case. The current report demonstrated the first case series of COVID-19-associated GBS-cases in Sudan.

Indexed as

ascending paraesthesiaCOVID‐19Guillain‐Barre syndromeinfectious diseaseneurological manifestationneurologySudan

Identifiers

PMID36852114
PMCPMC9957700

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.